Category: New products
-
Biotech Drug Shown to Kill Prostate Tumor Cells
Tests with lab mice show low doses of an experimental oral drug can selectively kill prostate cancer cells while not affecting surrounding healthy tissue.
-
Nasal Spray Reduces Flu Duration in Challenge Trial
An influenza vaccine given as a nasal spray is shown in a clinical trial to reduce the amount of time participants have flu infections, when exposed to the virus.
-
Clinical Trial Underway Testing Influenza Vaccine Patch
A clinical trial has begun testing a commercially-available flu vaccine administered with a painless patch device against conventional syringe injection delivery.
-
Green Energy Chemical Company Starts-Up, Raises $15M
A new enterprise, spun-off from labs at Northwestern University, says it’s designing electrochemical processes and systems for nanoscale materials to help meet the climate crisis.
-
Data Support Placebo Group Alternatives in Rare Disease Trials
Findings from a review of medical data and records indicate matched genetic control groups may not be needed in clinical trials testing treatments for Duchenne muscular dystrophy.
-
AI-Aided Mobile App Shown to Screen for Melanoma
The developer of an app using algorithms to analyze images of skin lesions says clinical trial findings show the system detects melanoma more reliably than some physicians.
-
Allergy Antibody Biotech Gains $40M in New Funds
A biotechnology enterprise creating engineered antibodies to treat severe food allergies is raising $40 million in its second venture financing round.
-
Start-Up Creating Software to Simplify Biomedical Analytics
A new enterprise began public operations to provide researchers with better analytical tools for making sense of mountains of complex genomics and related biomedical data.
-
Autism Device Company Gains Venture Funds, Joins Incubator
A new company creating precision light-activated treatments for autism spectrum disorder symptoms is raising more seed funds and joining a start-up incubator program.
-
Light-Activated Treatment Kills Covid-19 Nasal Viruses
Clinical trial findings show a light-activated disinfectant process kills SARS-CoV-2 viruses in the nose causing Covid-19 infections without harming nasal tissue.